glp 1 clinical studies GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Can one drug do it

Leslie Lotano-Saba has more than 35 years of pharmacy experience, primarily in government programs with payers and PBMs

Graves' eye disease, also called Graves' ophthalmopathy, is an eye condition that develops in people with an overactive thyroid caused by Graves' disease

GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for people with knee osteoarthritis and obesity, with tirzepatide providing greater health benefits at lower cost compared to semaglutide

Designed with the nutritional needs of GLP-1 medication users in mind, each pouch mixes easily with just cold water

A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial

Fromutilizationto mortality assumptions, these medications raise new costand risk considerations for actuaries and insurers. By Kimberly Ferrero GLP-1 medications(Glucagon-like peptide-1 receptor agonists) did not begin their clinical lives as weight-loss drugs